Back to top

Why Merck (MRK) is a Great Dividend Stock Right Now

Read MoreHide Full Article

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.

While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's often viewed by its dividend yield, a metric that measures a dividend as a percent of the current stock price. Many academic studies show that dividends account for significant portions of long-term returns, with dividend contributions exceeding one-third of total returns in many cases.

Merck in Focus

Headquartered in Kenilworth, Merck (MRK - Free Report) is a Medical stock that has seen a price change of 5.84% so far this year. The pharmaceutical company is paying out a dividend of $0.55 per share at the moment, with a dividend yield of 2.72% compared to the Large Cap Pharmaceuticals industry's yield of 2.78% and the S&P 500's yield of 1.96%.

Looking at dividend growth, the company's current annualized dividend of $2.20 is up 10.6% from last year. Merck has increased its dividend 5 times on a year-over-year basis over the last 5 years for an average annual increase of 2.88%. Any future dividend growth will depend on both earnings growth and the company's payout ratio; a payout ratio is the proportion of a firm's annual earnings per share that it pays out as a dividend. Merck's current payout ratio is 51%. This means it paid out 51% of its trailing 12-month EPS as dividend.

Looking at this fiscal year, MRK expects solid earnings growth. The Zacks Consensus Estimate for 2019 is $4.65 per share, with earnings expected to increase 7.14% from the year ago period.

Bottom Line

Investors like dividends for many reasons; they greatly improve stock investing profits, decrease overall portfolio risk, and carry tax advantages, among others. But, not every company offers a quarterly payout.

Big, established firms that have more secure profits are often seen as the best dividend options, but it's fairly uncommon to see high-growth businesses or tech start-ups offer their stockholders a dividend. Income investors have to be mindful of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, MRK is a compelling investment opportunity. Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of 3 (Hold).




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Merck & Co., Inc. (MRK) - free report >>

More from Zacks Tale of the Tape

You May Like

Published in